Senior Medical Director, Global Medical Affairs - Oncology

Janssen Oncology Global Medical Affairs, a member of Johnson & Johnson's Family of Companies, is recruiting for a Senior Medical Director for Multiple Myeloma. The preferred locations for this position are Bridgewater/Raritan, NJ however, remote work options may be considered on a case-by-case basis and if approved by the company.

At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found. 

We are Janssen. Our mission drives us. Our patients inspire us. We collaborate with the world for the health of everyone in it.

The Senior Medical Director Multiple Myeloma will be a member of the Global Medical Affairs team, leading the conduct of a global clinical study using the portfolio of compounds at Janssen with the aim of building curative regimens for patients with multiple myeloma. The Senior Medical Director will work under the leadership of the Head of Myeloma and Plasma Cell Disorders, Global Medical Affairs, with the focus on leading a global medical affairs worldwide study. In addition, they will work closely with senior R&D Clinical Leaders of myeloma asset teams, working closely towards the goal of advancing the science and development of our myeloma compounds towards cure. The Senior Medical Director will be a standing member of the Global Medical Affairs Leadership team, Global Medical Affairs teams, and an ad hoc member of the myeloma clinical teams.

 The role requires a high-performing and energetic individual who demonstrates outstanding scientific knowledge applicable to hematology clinical research and the highest personal and ethical standards. Experience in running and the conduct of global or highly complex studies is a key area of expertise needed for this individual.

The Senior Medical Director will lead the development of protocol writing for and operational execution of this new multiple myeloma clinical studies. They will also be critically involved in external engagement of myeloma experts involved in this study, both supporting the scientific advocacy and scientific engagement of the medical community. The Senior Medical Director will participate in the interpretation and reporting of the results of the research, including any appropriate health authority interaction. They will also evaluate scientific information and new ideas to assist in identifying new research opportunities. The Senior Medical Director Myeloma will also support other clinically related medical affairs activities across our myeloma portfolio around our pursuit of building regimens towards cure. They will also assess external clinical research proposals involving company products and manuscripts that are being prepared for publication. The Senior Medical Director will act as a liaison between the company and clinical investigators. Importantly, they will lead the internal study working group for this global study, working with R&D cand regional Medical Affairs colleagues.